Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
A randomized controlled trial of Control-IQ, assessing glycemic control (time-in-range 70-180 mg/dL) for Lyumjev insulin (in which the insulin settings have been determined using an experimental conversion factor) as compared to Humalog or Novolog (using optimized settings)
Epistemonikos ID: 16eed048453556bccfda6dcc42cd5f5e87466c4a
First added on: Apr 30, 2025